UPL Limited is a global provider of sustainable agriculture products — crop protection chemicals, seeds and specialty chemicals — and its Q2 print arrives with the monsoon season closed 12.2% below normal, the weakest since 2015. The key things the results will speak to are whether the FY27 guidance of 7-11% revenue and 10-14% EBITDA growth survives its stated weather and West Asia assumptions, and how margins hold against the 18.3% EBITDA margin base of Q2 FY26.
| Results date | November 02, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 10,181 Cr (+10% YoY) |
| Previous quarter PAT | PATMI Rs. 10 Cr |
| Previous quarter EBITDA margin | 14.7% (+60 bps) |
| Net debt (latest quarter) | $2.5 Bn at June 2026 |
| Market cap | Rs. 45,393.89 Cr |
| CMP | Rs. 536.4 |
The board meets on November 2, 2026 to consider the Q2/H1 FY27 unaudited financial results with Limited Review Reports, under Regulation 29 of SEBI LODR.
An earnings call is scheduled for 16:00 IST on November 2, 2026, the same day as the board meeting. The trading window for Designated Persons has been closed from September 30, 2026 until 48 hours after results dissemination.
The Q2 print will test whether UPL's FY27 guidance of 7-11% revenue growth and 10-14% EBITDA growth stays intact, after the two conditions management attached to it — no further adverse weather including El Nino, and no major West Asia escalation — were both tested during the July-September window. The India kharif season closed 12.2% below normal with August rainfall at 84% of LPA and September at 92%, and Q1 FY27 standalone India revenue had already declined 15.84% YoY on the delayed monsoon; group volumes were (3)% in Q1 with UPL Corp at (7)% and UPL SAS at (8)%, and management has said it expects volume recovery in the global crop protection business. On costs, WPI inflation accelerated to 11.39% in September, August international sulphur prices were up 262% YoY and ammonia up 23% YoY, and UPL's Q1 working-capital build was attributed to higher replacement input costs ahead of the Q2 season — against a demanding Q2 FY26 EBITDA margin base of 18.3%. Offsetting factors include the ~1.5% rupee depreciation over the window (94.33 to 95.79) that supports the 140+ country export book where FX added +10% to Q1 revenue growth, and Brazil's planting season opening with healthy demand and the Bloomberg Agriculture Spot Index up 13% in the three months through September. Working capital is the other watch-point: NWC stood at 110 days at Q1 FY27, up ~24 days YoY, with S&P expecting fiscal 2027 working capital requirements to rise by INR 14 billion, and the US$500 Mn sustainability-linked term loan maturing December 2026. The call will likely cover whether the 7-11% / 10-14% ranges are reaffirmed, narrowed or re-based, alongside updates on the Composite Scheme, the Advanta IPO and the Hytech Egypt acquisition approvals due on or before January 31, 2027.
FY27 guidance tracking: Management maintained FY27 guidance at the Q1 release, explicitly conditioned on no further adverse weather and no major West Asia escalation.
Deleveraging path and December 2026 maturity
Working capital normalization
Composite Scheme of Arrangement
Volume recovery in crop protection
SEBI approval for the Advanta IPO was received by Q1 FY27, and the Q1 release flagged value unlocking of the seeds and post-harvest businesses. Earlier, management had said it had 'nothing material to share on the IPO at this time', and the next concrete milestone — timeline and structure — remains open.
Management detailed a ~$30 Mn sales postponement from Q3 to Q4 FY26 due to tariff uncertainties and is moving formulation capability to the US to mitigate 50% tariffs on imported formulated products. Progress on US localization is a natural follow-up on the upcoming call.
Management confirmed $500 Mn of debt was repaid from internal accruals and $400 Mn of maturities were extended to 2029. Gross debt was reduced by $850 Mn in FY26 to $2,325 Mn, with net debt/EBITDA at 2.4x at Q1 FY27.
Q1 FY27 revenue growth of +10% landed at the low end of the 10-14% Q1 guidance, and EBITDA growth of +15% was within the guided 14-18% range. FY27 guidance stands at 7-11% revenue growth and 10-14% EBITDA growth, conditioned on no further adverse weather and no major West Asia escalation.